Recruiting NCT03275480
Institut Paoli Calmettes Myelodysplastic Syndromes Database
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Myelodysplastic Syndromes. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes
Primary outcome measures
- Survival of patients with myelodysplastic syndrome(MDS) [Time frame: 10 years]
Secondary outcome measures (1)
- Collection of patients characteristics [Time frame: 10 years]
Eligibility criteria
Inclusion criteria
- Patient with a diagnosis of Myelodysplastic Syndromes
Exclusion criteria
- None
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Institut Paoli-Calmettes — Marseille
Identifiers
NCT: NCT03275480 · BDD-SMD-IPC